These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1645721)

  • 1. Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region.
    Hanna PC; Mietzner TA; Schoolnik GK; McClane BA
    J Biol Chem; 1991 Jun; 266(17):11037-43. PubMed ID: 1645721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning of the 3' half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity.
    Hanna PC; Wnek AP; McClane BA
    J Bacteriol; 1989 Dec; 171(12):6815-20. PubMed ID: 2556374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli.
    Czeczulin JR; Hanna PC; McClane BA
    Infect Immun; 1993 Aug; 61(8):3429-39. PubMed ID: 8335373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of receptors for Clostridium perfringens type A and cholera enterotoxins in isolated rabbit intestinal brush border membranes.
    Wnek AP; McClane BA
    Microb Pathog; 1986 Feb; 1(1):89-100. PubMed ID: 2854596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico design of a novel chimeric shigella IpaB fused to C terminal of clostridium perfringens enterotoxin as a vaccine candidate.
    Arabshahi S; Nayeri Fasaei B; Derakhshandeh A; Novinrooz A
    Bioengineered; 2018 Jan; 9(1):170-177. PubMed ID: 29091543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Clostridium perfringens enterotoxin region required for large complex formation and cytotoxicity by random mutagenesis.
    Kokai-Kun JF; Benton K; Wieckowski EU; McClane BA
    Infect Immun; 1999 Nov; 67(11):5634-41. PubMed ID: 10531210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant C-terminal toxin fragment provides evidence that membrane insertion is important for Clostridium perfringens enterotoxin cytotoxicity.
    Hanna PC; McClane BA
    Mol Microbiol; 1991 Jan; 5(1):225-30. PubMed ID: 2014001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanylyl cyclase is a heat-stable enterotoxin receptor.
    Schulz S; Green CK; Yuen PS; Garbers DL
    Cell; 1990 Nov; 63(5):941-8. PubMed ID: 1701694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin.
    Katahira J; Inoue N; Horiguchi Y; Matsuda M; Sugimoto N
    J Cell Biol; 1997 Mar; 136(6):1239-47. PubMed ID: 9087440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of monoclonal antibodies against Clostridium perfringens type A enterotoxin.
    Wnek AP; Strouse RJ; McClane BA
    Infect Immun; 1985 Nov; 50(2):442-8. PubMed ID: 2865210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo.
    Katahira J; Sugiyama H; Inoue N; Horiguchi Y; Matsuda M; Sugimoto N
    J Biol Chem; 1997 Oct; 272(42):26652-8. PubMed ID: 9334247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic peptide corresponding to the extracellular loop 2 region of claudin-4 protects against Clostridium perfringens enterotoxin in vitro and in vivo.
    Shrestha A; Robertson SL; Garcia J; Beingasser J; McClane BA; Uzal FA
    Infect Immun; 2014 Nov; 82(11):4778-88. PubMed ID: 25156725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of a C. perfringens enterotoxin mutant in complex with a modified Claudin-2 extracellular loop 2.
    Yelland TS; Naylor CE; Bagoban T; Savva CG; Moss DS; McClane BA; Blasig IE; Popoff M; Basak AK
    J Mol Biol; 2014 Sep; 426(18):3134-3147. PubMed ID: 25020226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion analysis of the Clostridium perfringens enterotoxin.
    Kokai-Kun JF; McClane BA
    Infect Immun; 1997 Mar; 65(3):1014-22. PubMed ID: 9038311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning in Escherichia coli of the enterotoxin gene from Clostridium perfringens type A.
    Iwanejko LA; Routledge MN; Stewart GS
    J Gen Microbiol; 1989 Apr; 135(4):903-9. PubMed ID: 2557378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression from the Clostridium perfringens cpe promoter in C. perfringens and Bacillus subtilis.
    Melville SB; Labbe R; Sonenshein AL
    Infect Immun; 1994 Dec; 62(12):5550-8. PubMed ID: 7960138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organization of the plasmid cpe Locus in Clostridium perfringens type A isolates.
    Miyamoto K; Chakrabarti G; Morino Y; McClane BA
    Infect Immun; 2002 Aug; 70(8):4261-72. PubMed ID: 12117935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of heat-stable enterotoxin receptor activity by a human Alu repeat.
    Almenoff JS; Jurka J; Schoolnik GK
    J Biol Chem; 1994 Jun; 269(24):16610-7. PubMed ID: 8206979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of multiple antigenic determinants of Clostridium perfringens enterotoxin as revealed by use of different synthetic peptides.
    Sugii S
    J Vet Med Sci; 1994 Dec; 56(6):1047-50. PubMed ID: 7535106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the recombinant human receptor for Escherichia coli heat-stable enterotoxin.
    de Sauvage FJ; Horuk R; Bennett G; Quan C; Burnier JP; Goeddel DV
    J Biol Chem; 1992 Apr; 267(10):6479-82. PubMed ID: 1313005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.